Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

Expert Rev Ophthalmol. 2008;3(3):311-323. Choroidal neovascularization in PM has been treated with different approaches, which include laser photocoagulation, submacular surgery, photodynamic ...

Axitinib is under development for the treatment of choroidal neovascularization and wet age-related macular degeneration. The drug candidate is administered in suprachoroidal space through a micro ...

The following is a summary of “Phase 1 Study of JNJ-81201887 Gene Therapy in Geographic Atrophy Secondary to Age-Related ...

On November 18, 2024, Samsung Bioepis announced that the European Commission (EC) has approved its aflibercept biosimilar, OPUVIZ.

The various in vivo studies on posterior ciliary arteries and choroidal vasculature reported piecemeal by the author over the past few years have now been collated. A coherent picture of the ...

branch or central RVO), visual impairment due to diabetic macular edema (DME), and visual impairment due to myopic choroidal neovascularization (myopic CNV). 1 In the press release 1, Byoungin Jung, ...

FYB203 has been recommended by the CHMP for approval in Europe for treating adult patients with age-related neovascular macular degeneration (nAMD) and other serious retinal diseases such as diabetic ...

Kaiser: I couldn't agree more. We knew that it helps prevent progression late, mainly in CNV [choroidal neovascularization], but this also says that a patient with GA should also be on these ...

They explained, “We found that, among the candidates tested, RUNX1-Trap (CBFβ-SMMHCΔ95) could be used as a therapeutic agent to reduce cell proliferation in vitro; it also suppressed fibrotic membrane ...